Concarlo Holdings
Mike Harrington is a corporate executive and board member with 25 years of experience building global organizations and promoting corporate priorities in the heavily regulated life sciences industry. He has a history of increasing value across Eli Lilly’s worldwide operations through long-range vision, operational excellence and acquisitions. He provides a multidimensional perspective on corporate governance, strategic planning, enterprise risk management, and information security in regulated environments. He is also a current board member at Elanco Animal Health.
This person is not in the org chart
This person is not in any offices
Concarlo Holdings
Concarlo is a precision-medicine oncology company focused on diagnosing and treating cancer with an innovative approach to targeting a unique cellular pathway - p27Kip1.